Catalysts function by providing an alternate reaction mechanism that has a lower activation energy than would be found in the absence of the catalyst. In a patent, 147959-19-1, molecular formula is C12H21NO4, introducing its new discovery. 147959-19-1
OXAZOLINE DERIVATIVES FOR TREATMENT OF CNS DISORDERS
The invention relates to compounds of formula (I) wherein the definitions of X, R and R1 are provided in claim 1. It has now been found that the compounds of formula (I) have a good affinity to the trace amine associated receptors (TAARs), especially for TAAR1. The compounds may be used for the treatment of depression, anxiety disorders, bipolar disorder, attention deficit hyperactivity disorder (ADHD), stress-related disorders, psychotic disorders such as schizophrenia, neurological diseasessuch as Parkinson?s disease, neurodegenerative disorders such as Alzheimer?s disease, epilepsy, migraine, hypertension, substance abuse and metabolic disorders such as eating disorders, diabetes, diabetic complications, obesity, dyslipidemia, disorders of energy consumption and assimilation, disorders and malfunction of body temperature homeostasis, disorders of sleep and circadianrhythm, and cardiovascular disorders.
147959-19-1, If you are hungry for even more, make sure to check my other article about 147959-19-1
Reference£º
Oxazolidine – Wikipedia,
Oxazolidine | C3H2324NO – PubChem